COVID-19患者的血液学参数:与疾病严重程度的关联
A A Abdulla1, T Abdulaali Abed1, E Fadhel Abbas Awadh1
1Department of Biology, College of Sciences, University of Babylon, Babylon, Iraq.
Archives of Razi Institute
|June 5, 2023
概括
这项研究发现,较低的淋巴细胞计数和较高的中性粒细胞与淋巴细胞比率 (NLR) 与严重的COVID-19有关. 升高的IL6,CRP和S-ferritin水平也表明患者的疾病严重程度增加.
科学领域:
- 血液学 血液学 血液学
- 传染性疾病 传染性疾病
- 临床医学 临床医学
背景情况:
- 由SARS-CoV-2引起的COVID-19呈现出一系列的疾病严重程度.
- 了解与COVID-19严重程度相关的血液学标记对于患者管理至关重要.
- 以前的研究表明,炎症标志物在COVID-19病变发生过程中起着作用.
研究的目的:
- 在未接种疫苗的伊拉克患者中调查各种血液标志物与COVID-19的严重程度之间的关联.
- 确定可以预测或反映COVID-19严重程度的关键血液学指标.
主要方法:
- 一项涉及76名未接种疫苗的伊拉克COVID-19患者 (2020年9月至2021年3月) 的横截面研究.
- 根据临床表现,评估疾病严重程度 (轻度,中度,严重).
- 血液学参数的分析,包括白细胞 (WBC) 计数,中性粒细胞与淋巴细胞的比率 (NLR),IL6,C反应蛋白 (CRP),D-二聚体和S-费里丁.
主要成果:
- 与轻度和中度病例相比,重病患者的淋巴细胞数量显著降低.
- 在严重的COVID-19病例中观察到中性粒细胞与淋巴细胞比率 (NLR) 的显著增加.
- 升高的IL6,CRP和S-ferritin血清水平与严重疾病有显著的关联,IL6与严重程度具有高度显著的正相关性.
结论:
- 淋巴细胞计数和NLR是评估COVID-19严重程度的宝贵血液学标记.
- 血清IL6,CRP和S-ferritin水平在严重的COVID-19中显著升高,与疾病进展相关.
- 这些发现可以帮助临床评估和管理COVID-19患者.
相关概念视频
Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
Blood Transfusion and Agglutination
10.9K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
10.9K
Role of Hematopoietic Growth Factors
1.4K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
1.4K
Disorders of Hemostasis
1.0K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.0K
Disorders of Erythrocytes
1.0K
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
1.0K


